Key result
Electrocardiographic diagnosis of left ventricular hypertrophy predicts cardiovascular events in hypertensive patients, though improving its diagnostic sensitivity remains a clinical challenge.
Why the study?
Although widely used for screening, low sensitivity in the electrocardiographic diagnosis of left ventricular hypertrophy remains a significant clinical challenge.
Answers are grounded in this paper and cite their sources.
ECG diagnosis of LVH remains a crucial, albeit insensitive, tool for risk stratification in hypertensive patients, with AI offering potential improvements in diagnostic accuracy.
Electrocardiography (ECG) is a relatively inexpensive and easily conducted test, and it is widely used for screening left ventricular hypertrophy (LVH). In 1969, Romhilt et al. reported the sensitivity and specificity of the diagnostic criteria for LVH in 360 autopsy hearts.1 The best limb-lead criterion was RaVL >0.75 mV which had 22.5% sensitivity with only 3.5% false positives, and the chest-lead criteria had 56% sensitivity but 10.5%–14.5% false positives.1 The Sokolow–Lyon criterion is a simple and easy-to-use indicator of LVH, but its specificity is relatively low. Reichek et al. showed a weak correlation between the ECG diagnosis of LVH and autopsy left ventricular weight, with a Sokolow–Lyon voltage correlation coefficient of only r = 0.30, 21% sensitivity, and 95% specificity.2 Cornell voltage (RaVL + SV3 > 2.8 mV, 2.0 mV) is also not very sensitive, but its sensitivity increases when it is combined with the QRS width product (Cornell product). However, the low sensitivity in the ECG diagnosis of LVH has been a problem. The ECG diagnosis of LVH was shown to be useful for prognosis prediction in the Framingham Study.3 The ECG diagnosis of LVH is not only a predictor of prognosis; it is also associated with cardiovascular events, other hypertensive organ damage, and atrial fibrillation.4–9 In our prior study of a Japanese general population, we observed that the ECG diagnosis of LVH by the Cornell product criteria was present in 11.0% of hypertensives and that there was a 1.41 times higher risk of stroke in the hypertensives (95% confidence interval: 0.99–2.02), our analyses revealed that both ECG diagnosis of LVH by the Cornell product criteria and that by the Sokolow–Lyon criteria are risk factors for stroke in the Japanese general population.4 In elderly hypertensive patients, patients with LVH by the Sokolow–Lyon criteria had a 3.5–4.2 times higher incidence of cardiovascular events.5 In a meta-analysis, Zhang et al. showed that the rate of cardiovascular events was 1.53 times higher based on the Sokolow–Lyon voltage and 1.46 times higher based on the Cornell voltage in hypertensive patients.6 There is also a study of LVH identified based on the Cornell product and renal dysfunction,7 and a report that the combination of the ECG diagnosis of LVH and renal impairment predicts the prognosis in patients with vascular diseases.8 The ECG diagnosis of LVH was shown to be able to predict the onset of atrial fibrillation.9 The Losartan Intervention For Endpoint reduction (LIFE) study and the Heart Outcome Prevention Evaluation (HOPE) study have shown the association between the regression of LVH on ECG due to antihypertensive treatment and reductions of the risk of cardiovascular events and death.10,11 Thus, the ECG diagnosis of LVH is being used as guidelines for hypertension in several countries. In addition to Sokolow–Lyon voltage and Cornell voltage, the prediction of LVH using various electrocardiographic indices has been described. Okin et al. investigated 212 autopsy cases and evaluated 7 electrocardiographic LVH diagnostic criteria (the Sokolow–Lyon voltage, Cornell voltage, adjusted Cornell voltage, Cornell product, Romhilt–Estes point score, Novacode score, and Cornell multivariate score) and compared their diagnostic accuracies. Of the 7 criteria, the Cornell product had the highest diagnostic accuracy (52% sensitivity and 95% specificity).12 MacFarlane et al. showed indicated that the diagnostic accuracy was improved by combining the criteria for the ECG diagnosis of LVH13; however, the diagnostic accuracy of scoring the criteria for detecting LVH is not high and is complicated, and it has not been widely applied clinically. Although Wang et al. showed that the Cornell product had high diagnostic accuracy among 7 diagnostic criteria (i.e., the Sokolow–Lyon voltage, Cornell voltage index, Cornell product, Gubner index, RaVL voltage, RV5 or RV6 voltage, and Lewis voltage), the sensitivity was only 31.9%, but when any of the 4 electrocardiograms (Sokolow–Lyon voltage, Cornell voltage, Cornell product, and RaVL voltage) was positive for each criterion, the sensitivity of LVH evaluated by echocardiography was improved to 54%.14 The 4 ECG-based diagnostics for LVH had relatively good sensitivity for concentric LVH, but low sensitivity for eccentric LVH.14 Concentric LVH is caused by hypertension and aortic stenosis due to systemic pressure overload, and eccentric LVH is often caused by left ventricular volume overload (e.g., valve disease) or dilated cardiomyopathy. It is necessary to identify the precise patient population for whom the ECG diagnostic criteria for LVH should be used, and further improvements of ECG’s diagnostic accuracy of eccentric LVH are needed. The progression of LVH in hypertension is explained by increased afterload due to arteriosclerosis, which is the main pathology of hypertension (Figure 1). An increase in afterload leads to an increase in the left ventricular end diastolic pressure and further to an increase in left atrial pressure. An increase in afterload also leads to ventricular remodeling, concentric LVH, and left atrial electrical and structural remodeling. As a result of ventricular remodeling, an R-wave increase and ST–T change are shown, and as a result of atrial remodeling, the P-wave morphology change and PR are prolonged. Finally, concentric LVH proceeds to eccentric LVH with a reduction in left ventricular systolic function, and electrocardiographic characteristics of patients with LVH include various changes such as prolonged QRS duration, left axis deviation, and abnormal P-wave.15,16 We measured the ST–T area in 834 individuals who participated in the J-HOP Study.17 Those with reduced ST–T areas and strain changes had been suffering from a significantly higher rate of cardiovascular events.17 We also reported that abnormal P-wave morphology (notched P-wave) was associated with a 1.59-fold higher cardiovascular event after adjusting for other ECG findings.18 Interestingly, in patients without LVH by the Sokolow–Lyon and Cornell product criteria, notched P-wave was significantly associated with cardiovascular events. In hypertensive cardiac remodeling, findings of atrial remodeling in cases without ventricular remodeling may be useful as tools to predict cardiovascular events. The progression of left ventricular hypertrophy and ECG findings in hypertensive individuals. Abbreviations: APC, atrial premature contraction; BP, blood pressure; CAVI, cardio-ankle vascular index; ECG, electrocardiography; FMD, flow-mediated dilatation; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LA, left atrium; LV, left ventriculum; PWV, pulse wave velocity; VPC, ventricular premature contraction. The progression of left ventricular hypertrophy and ECG findings in hypertensive individuals. Abbreviations: APC, atrial premature contraction; BP, blood pressure; CAVI, cardio-ankle vascular index; ECG, electrocardiography; FMD, flow-mediated dilatation; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LA, left atrium; LV, left ventriculum; PWV, pulse wave velocity; VPC, ventricular premature contraction. In recent years, the ECG detection of hypertrophic cardiomyopathy (HCM) using artificial intelligence has been performed. Ko et al. developed an algorithm for 2,448 HCM patients and age- and gender-matched 51,153 non-HCM patients, and they assessed the ability to diagnose HCM in 612 HCM patients and 12,788 controls with different datasets.19 Especially in young people (age <40 years), the diagnostic accuracy was very good (95% sensitivity and 92% specificity).19 Studies of the diagnosis of LVH by ECG using artificial intelligence are also being conducted. Kwon et al. created an algorithm using the ensemble neural network from the analysis of 35,694 ECGs from 1 hospital, and they performed an accuracy test on the dataset of another hospital (external).20 They used a neural network including not only ECG data but also demographic data to enhance the diagnostic accuracy. The area under the receiver operating characteristic curve of the artificial intelligence algorithm based on ensemble neural network was good with external data.20 The etiology of hypertensive patients varies, the findings of ECG in hypertensive patients show large individual differences compared with HCM, and there may be a limitation to the diagnosis of LVH using only ECG. In the future, detailed analyses of ECG will be possible with the use of automatic ECG analyses and artificial intelligence. Tracking various indicators of LVH over time may enable the better prediction of cardiovascular events. The authors declared no conflict of interest.
No takes yet. Share an insight, caveat, or question.
Kabutoya et al. (2020) conducted a review in Left ventricular hypertrophy in hypertensive individuals. Electrocardiographic diagnosis of left ventricular hypertrophy was evaluated. Electrocardiographic diagnosis of left ventricular hypertrophy predicts cardiovascular events in hypertensive patients, though improving its diagnostic sensitivity remains a clinical challenge.
Synapse has enriched 10 related papers. Consider them for comparative context: